"Nucleosides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
| Descriptor ID |
D009705
|
| MeSH Number(s) |
D09.408.595 D13.570
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nucleosides".
Below are MeSH descriptors whose meaning is more specific than "Nucleosides".
This graph shows the total number of publications written about "Nucleosides" by people in this website by year, and whether "Nucleosides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 3 | 0 | 3 |
| 2007 | 4 | 0 | 4 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nucleosides" by people in Profiles.
-
Liu YM, Wang S, Dickenson A, Mao J, Bai X, Liao X. An on-line SPE-LC-MS/MS method for quantification of nucleobases and nucleosides present in biological fluids. Anal Methods. 2024 Apr 25; 16(16):2505-2512.
-
Marikawa Y, Alarcon VB. An active metabolite of the anti-COVID-19 drug molnupiravir impairs mouse preimplantation embryos at clinically relevant concentrations. Reprod Toxicol. 2023 10; 121:108475.
-
Kapdi AR, Arseniyadis S, Lakshman MK. Nucleoside/Nucleotide or Nucleic Acid Modification & Applications. Chem Rec. 2023 Jan; 23(1):e202200252.
-
Lakshman MK. Base Modifications of Nucleosides via the Use of Peptide-Coupling Agents, and Beyond. Chem Rec. 2023 Jan; 23(1):e202200182.
-
Sebastian D, Satishkumar S, Pradhan P, Yang L, Lakshman MK. General Approach to N6,C5'-Difunctionalization of Adenosine. J Org Chem. 2022 01 07; 87(1):18-39.
-
Pogula PK, De Chatterjee A, Chi M, VanKoten HW, Das S, Patterson SE. Triazoxins: Novel nucleosides with anti-Giardia activity. Bioorg Med Chem Lett. 2020 06 15; 30(12):127175.
-
Satishkumar S, Lakshman MK. Benzimidazopurine nucleosides from N6-aryl adenosine derivatives by PhI(OAc)2-mediated C-N bond formation, no metal needed. Chem Commun (Camb). 2017 Feb 14; 53(14):2226-2229.
-
Basavapathruni A, Jin L, Daigle SR, Majer CR, Therkelsen CA, Wigle TJ, Kuntz KW, Chesworth R, Pollock RM, Scott MP, Moyer MP, Richon VM, Copeland RA, Olhava EJ. Conformational adaptation drives potent, selective and durable inhibition of the human protein methyltransferase DOT1L. Chem Biol Drug Des. 2012 Dec; 80(6):971-80.
-
Cohen CJ, Andrade-Villanueva J, Clotet B, Fourie J, Johnson MA, Ruxrungtham K, Wu H, Zorrilla C, Crauwels H, Rimsky LT, Vanveggel S, Boven K. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial. Lancet. 2011 Jul 16; 378(9787):229-37.
-
Brogly SB, DiMauro S, Van Dyke RB, Williams PL, Naini A, Libutti DE, Choi J, Chung M, Gerschenson M. Short communication: transplacental nucleoside analogue exposure and mitochondrial parameters in HIV-uninfected children. AIDS Res Hum Retroviruses. 2011 Jul; 27(7):777-83.